Estrella Immunopharma, Inc. Annual Net Cash Provided by (Used in) Investing Activities in USD from 2021 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Estrella Immunopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2021 to 2022.
  • Estrella Immunopharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending September 30, 2023 was -$112K.
  • Estrella Immunopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $36.2M.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $36.2M +$81.4M Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 -$45.2M Jan 6, 2021 Dec 31, 2021 10-K 2023-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.